NEW YORK, May 2, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX ) , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory ...

Cardiff Oncology has sufficient funds to operate until early 2027 but will face funding challenges by 2026. Learn why CRDF ...

Log9 Materials went from making headlines for its bold claims around cutting-edge battery tech to completely falling apart?

April 30, 2025 /PRNewswire/ -- The Advanced Lateral Flow Conference (ALFC) is now accepting applications for poster presentations ... clinical operations, data management, and biostatistics ...

Presentation Title: GT-02287, A Clinical-stage Allosteric GCase Modulator For The Treatment Of Parkinson's Disease, Protects Dopaminergic Neurons Against Mitochondrial Toxin MPP+ Presenter: Joanne ...

SEC-registered investment adviser Two Prime ditched Ether trading and lending over the altcoin being “more like a memecoin,” ...

The Achievement Cliff The Silicon Valley CEO had built a $400 million company but dreaded Monday mornings—he was on ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Unai Simon, Spain’s Euro 24-winning keeper is on the bench not between the posts. But that’s because his deputy Julen ...

SJW Group is trading at a discount, making it a compelling long-term investment. Learn why SJW stock is a Buy.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...